These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 28052030

  • 21. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM, Narayanan R, Lu Y, Hurh E, Coss CC, Barrett CM, Miller DD, Dalton JT.
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [Abstract] [Full Text] [Related]

  • 22. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
    Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Maeda N, Sakaue H, Masuzaki H, Shimomura I, Sata M.
    Cardiovasc Diabetol; 2012 Nov 08; 11():139. PubMed ID: 23137106
    [Abstract] [Full Text] [Related]

  • 23. Berberine displays antitumor activity in esophageal cancer cells in vitro.
    Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF, Zhao Y, Liu YZ, Zhao BS.
    World J Gastroenterol; 2017 Apr 14; 23(14):2511-2518. PubMed ID: 28465635
    [Abstract] [Full Text] [Related]

  • 24. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
    Akashi E, Fujihara S, Morishita A, Tadokoro T, Chiyo T, Fujikawa K, Kobara H, Mori H, Iwama H, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T.
    Oncol Rep; 2017 Jul 14; 38(1):506-514. PubMed ID: 28586026
    [Abstract] [Full Text] [Related]

  • 25. Telmisartan-Induced Cytotoxicity via G2/M Phase Arrest in Renal Cell Carcinoma Cell Lines.
    Tsujiya Y, Hasegawa A, Yamamori M, Okamura N.
    Biol Pharm Bull; 2021 Jul 14; 44(12):1878-1885. PubMed ID: 34853271
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Pan SY, Chen XW, Zhou SF.
    Drug Des Devel Ther; 2015 Jul 14; 9():1293-318. PubMed ID: 25767376
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F, Li H, Yan XG, Zhou ZW, Yi ZG, He ZX, Pan ST, Yang YX, Wang ZZ, Zhang X, Yang T, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Jul 14; 9():575-601. PubMed ID: 25632225
    [Abstract] [Full Text] [Related]

  • 32. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.
    Okazaki M, Fushida S, Harada S, Tsukada T, Kinoshita J, Oyama K, Tajima H, Ninomiya I, Fujimura T, Ohta T.
    Cancer Lett; 2014 Dec 01; 355(1):46-53. PubMed ID: 25224569
    [Abstract] [Full Text] [Related]

  • 33. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
    Chang WL, Hsu LC, Leu WJ, Chen CS, Guh JH.
    Oncotarget; 2015 Nov 24; 6(37):39806-20. PubMed ID: 26447757
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.
    Kebenko M, Drenckhan A, Gros SJ, Jücker M, Grabinski N, Ewald F, Grottke A, Schultze A, Izbicki JR, Bokemeyer C, Wellbrock J, Fiedler W.
    Cell Signal; 2015 Feb 24; 27(2):373-81. PubMed ID: 25435423
    [Abstract] [Full Text] [Related]

  • 36. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K, Ohishi M, Ho C, Kurtz TW, Rakugi H.
    Hypertension; 2009 Dec 24; 54(6):1353-9. PubMed ID: 19822796
    [Abstract] [Full Text] [Related]

  • 37. Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells.
    Zhao L, Wen ZH, Jia CH, Li M, Luo SQ, Bai XC.
    Anat Rec (Hoboken); 2011 Aug 24; 294(8):1337-43. PubMed ID: 21717584
    [Abstract] [Full Text] [Related]

  • 38. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
    Mikami D, Kimura H, Kamiyama K, Torii K, Kasuno K, Takahashi N, Yoshida H, Iwano M.
    Hypertens Res; 2014 May 24; 37(5):422-31. PubMed ID: 24352213
    [Abstract] [Full Text] [Related]

  • 39. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X, Mao T, Li S, He J, Hou X, Li H, Zhan M, Yang X, Li R, Xiao J, Yuan S, Sun L.
    Phytomedicine; 2019 Feb 15; 54():120-131. PubMed ID: 30668361
    [Abstract] [Full Text] [Related]

  • 40. Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.
    Siragusa M, Sessa WC.
    Arterioscler Thromb Vasc Biol; 2013 Aug 15; 33(8):1852-60. PubMed ID: 23702662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.